Cover image of the article: Efficacy of Cognitive Therapy on Meta-Worry and Experiential Avoidance in Individuals with Panic Disorder (AI-generated illustration)

Image Credit:AI-generated illustration

Efficacy of Cognitive Therapy on Meta-Worry and Experiential Avoidance in Individuals with Panic Disorder

Authors

Nazanin Zahra AriamaneshNazanin Zahra Ariamanesh ORCID1, Rezvan HomaeiRezvan Homaei ORCID1,*, Fariba Zargar ShiraziFariba Zargar Shirazi ORCID2, Sadrollah KhosraviSadrollah Khosravi ORCID3, Zahra Dasht BozorgiZahra Dasht Bozorgi ORCID1

Abstract

Background:

Panic disorder is characterized by recurrent, unexpected panic attacks that are often exacerbated and maintained by cognitive dysfunctions, particularly meta-worry and experiential avoidance.

Objectives:

This study evaluated the efficacy of cognitive therapy in reducing meta-worry and experiential avoidance among individuals with panic disorder and the short-term maintenance of these effects.

Methods:

This clinical trial used a pretest-posttest design with a two-month follow-up. A total of 20 patients aged 18 - 45 years with panic disorder were recruited through purposive sampling from psychological clinics in Shiraz, Iran, during 2025. Participants were allocated to an experimental group (n = 10) or a waitlist control group (n = 10). The experimental group received ten 90-minute sessions of protocolized cognitive therapy delivered twice weekly. Data were collected at baseline, postintervention, and follow-up using the Meta-Worry Questionnaire and the Experiential Avoidance Scale. Data were analyzed using repeated-measures analysis of variance.

Results:

Repeated-measures analysis of variance demonstrated significant time-by-group interaction effects. Compared with the control group, the experimental group showed substantial posttreatment reductions in both meta-worry and experiential avoidance (P < 0.001). These therapeutic gains were sustained within the experimental group at the two-month follow-up.

Conclusions:

Cognitive therapy reduces transdiagnostic maintenance mechanisms in panic disorder by restructuring catastrophic misinterpretations and enhancing emotional exposure. Sustained improvements relative to the control group highlight its utility as a durable nonpharmacological intervention.

How to Cite:Ariamanesh NZ, Homaei R, Zargar Shirazi F, Khosravi S, Dasht Bozorgi Z. Efficacy of Cognitive Therapy on Meta-Worry and Experiential Avoidance in Individuals with Panic Disorder. J Arch Mil Med. 2026;14(4):e174685. doi: https://doi.org/10.69107/jamm-174685

1. Background

Panic disorder disrupts an individual's cognitive evaluation of internal and environmental safety, extending beyond transient episodes of anxiety (1). Patients frequently misinterpret normal physiological fluctuations, such as an elevated heart rate or changes in respiration, as evidence of imminent catastrophe or death (2). This catastrophic misattribution prompts avoidance of potential triggers, including crowded spaces, traveling alone, or waiting in lines, substantially restricting daily functioning and contributing to social isolation (3). Even in the absence of acute panic attacks, individuals experience chronic anticipatory anxiety about their health and future episodes (4). Panic disorder has a global prevalence of approximately 2% to 3%, peaks in early adulthood, disproportionately affects women, and substantially impairs quality of life, necessitating targeted clinical interventions (5).
A key mechanism contributing to the maintenance and relapse of panic disorder is meta-worry, defined as the distressing tendency to worry about worrying itself (6). Meta-worry is central to metacognitive pathology and is underpinned by negative metacognitive beliefs, including beliefs that worry is uncontrollable, inherently dangerous, or capable of triggering a somatic crisis (7). According to Wells' metacognitive model, patients fear not only acute panic symptoms but also the loss of cognitive control over their emotional states (8). This secondary fear is often more distressing than the primary somatic apprehension, leading patients to monitor their cognitive and bodily signals excessively and thereby exacerbating the distress they seek to reduce (9).
Experiential avoidance is another important maintenance factor in panic pathology (10). It encompasses a persistent unwillingness to remain in contact with aversive internal experiences, including unpleasant emotions, intrusive thoughts, distressing memories, and somatic sensations (11). To escape these experiences, patients rely on maladaptive emotion-regulation strategies, such as thought suppression, distraction, or withdrawal from situations that provoke distress (12). Although these strategies may provide temporary relief from acute anxiety, they increase sensitivity to internal stimuli and reduce distress tolerance over time (13). Consequently, experiential avoidance hinders emotional processing and exposure, reinforcing the chronicity of panic disorder and preventing spontaneous recovery (14).
Despite advances in pharmacological treatments, particularly selective serotonin reuptake inhibitors, a substantial proportion of patients experience residual symptoms or relapses, highlighting the need for cognitive interventions (15). Cognitive therapy is a first-line psychological intervention that targets dysfunctional cognitive processes that maintain anxiety (16). It equips patients with skills to challenge and restructure catastrophic misinterpretations of benign physical symptoms and replace them with realistic, evidence-based evaluations (17). Cognitive therapy also counteracts experiential avoidance through structured emotional exposure (18). Rather than suppressing distress, patients are guided to confront anxiety-provoking stimuli safely, supporting adaptive emotion regulation and enduring changes in their cognitive schemas (19).
A growing body of literature supports the efficacy of cognitive interventions in addressing these cognitive vulnerabilities (20). Previous studies have demonstrated that cognitive therapy reduces meta-worry and improves subjective sleep quality in diverse patient populations (21). Related studies have also shown reductions in experiential avoidance and improvements in emotional expression among individuals experiencing severe emotional distress (22). Broader transdiagnostic research indicates that cognitive therapy reduces rumination, chronic worry, somatization, and emotional reactivity across anxiety and depressive disorders (23). A key clinical advantage of cognitive therapy is the sustainability of its effects, as cognitive restructuring may protect against future psychiatric relapse (24).
Despite the debilitating nature of panic disorder, contemporary interventions in Iran have predominantly focused on symptom reduction, often overlooking meta-worry and experiential avoidance as primary therapeutic targets. This gap in culturally contextualized research, particularly in Shiraz, hinders the development of comprehensive treatment protocols that address the underlying causes of psychological distress. Addressing these metacognitive and emotion-regulation deficits is essential for standardizing evidence-based care and reducing the socioeconomic burden of the disorder.

2. Objectives

This study aimed to investigate the efficacy of cognitive therapy in reducing meta-worry and experiential avoidance among individuals with panic disorder in Shiraz.

3. Methods

3.1. Study Design and Participants

This clinical trial used a pretest-posttest control-group design with a two-month follow-up and included individuals diagnosed with panic disorder in Shiraz, Iran, in 2025. Using purposive sampling, 20 eligible patients aged 18 - 45 years were recruited from local psychological counseling centers and allocated to an experimental group (n = 10) or a waitlist control group (n = 10). Inclusion criteria were a diagnosis of panic disorder by a clinical psychologist or psychiatrist based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), written informed consent, at least a high school diploma, and baseline scores exceeding clinical cutoffs on the study questionnaires. To control for confounding variables, patients were excluded if they were concurrently receiving psychiatric medication or other psychological interventions, missed more than two therapy sessions, experienced severe unforeseen stressful life events during the trial, or voluntarily withdrew from the study.

3.2. Instruments

Meta-Worry Questionnaire (MWQ): The metacognitive dimension of participants’ anxiety was assessed using the MWQ, developed by Wells and Cartwright-Hatton in 2004. This tool comprises seven items that quantify beliefs about the inherent dangers and uncontrollability of worrying. Higher total scores indicate more pronounced metacognitive pathology, wherein individuals perceive their own worry processes as catastrophic (25). The reported internal consistency of the Persian MWQ was 0.71 (26). In the present study, Cronbach’s alpha for the MWQ was 0.84.
Experiential Avoidance Scale (EAS): To assess patients’ rigid reluctance to engage with distressing internal states, the refined 10-item version of the EAS, originally conceptualized by Hayes et al. in 2004, was used. Participants rate statements on a seven-point Likert scale ranging from 1 (completely false) to 7 (completely true). Elevated scores signify a deeply ingrained pattern of cognitive and behavioral avoidance of unpleasant emotions and bodily sensations, which is recognized as a core maintenance factor in anxiety pathology (27). Previous Iranian normative studies have corroborated its structural integrity, reporting alpha values between 0.82 and 0.84 (28). The current study likewise found optimal internal consistency for this scale, with a Cronbach’s alpha of 0.82.

3.3. Intervention Program

The experimental group received a structured cognitive therapy program consisting of ten 90-minute sessions delivered twice weekly. The initial sessions focused on psychoeducation about the mind-body connection, an introduction to the cognitive-behavioral triangle, and training in identifying cognitive distortions and logical errors. Subsequent modules addressed cognitive restructuring and emotion regulation through thought-stopping exercises, positive imagery, and access to core emotions using Greenberg's emotional model. Mid-treatment sessions emphasized physiological desensitization through progressive muscle relaxation. Later sessions incorporated imaginal systematic desensitization, logical analysis of dysfunctional assumptions, and the downward arrow technique to identify maladaptive schemas. The final sessions focused on consolidating therapeutic gains through perceptual shifting and voluntary cortical inhibition exercises.

3.4. Data Analysis

Data were processed and analyzed using SPSS version 27. Repeated-measures analysis of variance (RM-ANOVA) was used to assess the effects of the intervention across the pretest, posttest, and follow-up phases. Least significant difference post hoc tests were used for pairwise comparisons.

4. Results

The final sample comprised 20 individuals with panic disorder: 10 in the cognitive therapy group and 10 in the waitlist control group. Participants were aged 18 - 45 years. The mean age was 29.80 years (standard deviation [SD] = 6.12) in the experimental group and 29.20 years (SD = 5.85) in the control group. The experimental group included 6 women (60.0%) and 4 men (40.0%), whereas the control group included 5 women (50.0%) and 5 men (50.0%). Independent-samples t tests and chi-square analyses showed no statistically significant baseline differences between the groups in age (P = 0.828) or gender distribution (P = 0.655).
Table 1 summarizes the means and standard deviations for meta-worry and experiential avoidance at baseline, postintervention, and the two-month follow-up. At baseline, both groups had comparably high levels of meta-worry and experiential avoidance. Following the intervention, the cognitive therapy group showed substantial reductions in both outcomes at posttest, and these gains were maintained at follow-up. In contrast, the waitlist control group maintained stable, elevated scores across all three assessment points, indicating no spontaneous symptomatic remission.
Table 1.
Descriptive Statistics for Outcome Variables Across Study Phases a
Variables and GroupsPretestPosttestFollow-up
Meta-worry
Experimental23.65 (3.67)10.12 (1.11)9.59 (1.27)
Control23.20 (3.50)22.90 (3.40)23.10 (3.60)
Experiential avoidance
Experimental50.24 (3.91)26.76 (3.70)26.18 (4.17)
Control49.80 (4.10)49.10 (3.95)49.50 (4.20)
a Values are expressed as mean (SD).
Before the RM-ANOVA, the statistical assumptions were assessed. Normality was confirmed across all study phases, with skewness ranging from -0.85 to +0.92 and kurtosis ranging from -0.78 to +1.10, within the acceptable range of -2.00 to +2.00. Levene's test supported homogeneity of error variances across groups for all variables at all assessment points (P > 0.05). Mauchly's test indicated that sphericity was met for experiential avoidance (P = 0.182) but violated for meta-worry (P = 0.008). The degrees of freedom for meta-worry were therefore adjusted using the Greenhouse-Geisser correction (ϵ = 0.68).
A series of 2 (group: experimental vs control) × 3 (time: pretest, posttest, and follow-up) mixed RM-ANOVAs was performed to evaluate treatment effects over time and between groups. As shown in Table 2, significant main effects of time and group were observed for both outcomes (P < 0.001). Significant time-by-group interactions were also found for meta-worry and experiential avoidance (P < 0.001), supporting the primary hypothesis. The effect sizes indicate that the reductions in psychological distress over time were attributable to the cognitive therapy intervention rather than temporal or retesting effects.
Table 2.
Mixed Repeated-Measures Analysis of Variance Results for Main and Interaction Effects a
Variables and SourcesSum of SquaresdfMean SquareFP ValuePartial η2
Meta-worry
Time1085.401.36798.09142.35< 0.0010.69
Group1120.8011120.80115.60< 0.0010.67
Time × Group978.601.36719.56128.45< 0.0010.68
Experiential avoidance
Time2215.3021107.65210.18< 0.0010.72
Group2450.6012450.60184.22< 0.0010.71
Time × Group2095.4021047.70198.75< 0.0010.72
a Abbreviation: df, degrees of freedom.
Fisher's least significant difference post hoc tests were used to examine pairwise differences between assessment points. As shown in Table 3, the experimental group had significant decreases from pretest to posttest in meta-worry (mean difference = 13.53, P < 0.001) and experiential avoidance (mean difference = 23.48, P < 0.001). There were no significant differences between posttest and follow-up in meta-worry (mean difference = 0.53, P = 0.132) or experiential avoidance (mean difference = 0.58, P = 0.550), indicating that the posttreatment improvements remained stable over the two-month follow-up. The control group showed no statistically significant changes across pairwise comparisons between assessment points (P > 0.05). Figure 1 illustrates the trajectories of both outcomes across the three study phases in the experimental and control groups.
Table 3.
Least Significant Difference Post Hoc Pairwise Comparisons Across Time Points in the Experimental Group
Variables and Comparison PhasesMean DifferenceStandard ErrorP Value95% Confidence Interval
Meta-worry
Pretest vs posttest13.530.97< 0.001(11.48, 15.58)
Pretest vs follow-up14.060.96< 0.001(12.03, 16.09)
Posttest vs follow-up0.530.340.132(-0.19, 1.25)
Experiential avoidance
Pretest vs posttest23.481.17< 0.001(20.99, 25.97)
Pretest vs follow-up24.061.08< 0.001(21.76, 26.36)
Posttest vs follow-up0.580.960.550(-1.46, 2.62)
Longitudinal change trajectories for meta-worry and experiential avoidance across pretest, posttest, and 2-month follow-up evaluation points in experimental and control groups.
Figure 1.
Longitudinal change trajectories for meta-worry and experiential avoidance across pretest, posttest, and 2-month follow-up evaluation points in experimental and control groups.

5. Discussion

This study examined the efficacy of protocolized cognitive therapy in addressing core transdiagnostic maintenance factors, specifically meta-worry and experiential avoidance, in individuals with panic disorder. The findings support sustained effects of cognitive therapy on the cognitive and behavioral processes that perpetuate panic symptoms. These psychological changes can be understood in terms of the mechanisms through which they disrupt the chronic cycle of panic.
The reduction in meta-worry supports the theoretical premise that targeting secondary cognitive appraisals provides clinical benefits. This finding is consistent with the transdiagnostic meta-analysis by Stenzel et al. (29), which demonstrated the efficacy of cognitive interventions in addressing maladaptive metacognitive processes in anxiety-related psychopathology. Meta-worry represents a secondary layer of distress in which patients catastrophize their cognitive processes and hold rigid beliefs that worry is uncontrollable, harmful, or capable of inducing a somatic crisis (8). Through techniques such as cognitive restructuring and detached mindfulness, the protocol challenged the perceived causal relationship between thinking about a panic attack and its actual physical occurrence. Patients learned to decenter cognitively and view catastrophic thoughts as transient mental events rather than physiological facts. Addressing this metacognitive process is important because patients may remain vulnerable to relapse while it persists, even if the frequency of acute panic attacks temporarily decreases.
The intervention also produced a sustained reduction in experiential avoidance. This finding is consistent with the outcomes reported by Piro and Taha (30) and supports the capacity of cognitive therapy to encourage emotional engagement rather than avoidance. Experiential avoidance in panic disorder often involves reliance on safety behaviors, such as carrying unnecessary anxiolytic medication, leaving agoraphobic situations, or suppressing distressing physiological arousal. These behaviors can amplify the perceived threat of somatic sensations and impede emotional processing. Cognitive therapy disrupts this cycle through gradual exposure to feared interoceptive cues, thereby developing distress tolerance (31). Through psychoeducation and controlled exposure exercises, patients restructured catastrophic misinterpretations of benign somatic sensations. For example, they learned through experience that a rapid heartbeat or breathlessness does not necessarily indicate an impending myocardial infarction or asphyxiation. This experiential learning promotes extinction of the conditioned fear response and demonstrates that tolerating short-term emotional and somatic discomfort can lead to sustained symptomatic relief.
The stability of the therapeutic gains at follow-up is an important aspect of these findings. The persistence of the improvements indicates that the cognitive and behavioral changes achieved during treatment reflect changes in coping strategies rather than transient fluctuations. By internalizing cognitive restructuring and interoceptive exposure techniques, patients acquire skills to manage symptoms independently. This self-efficacy enables them to apply adaptive emotion-regulation strategies when encountering new anxiety-provoking stimuli, reducing the risk of panic recurrence and improving quality of life. Integrating these cognitive modules into standard care could help reduce the socioeconomic burden of panic disorder.
Several methodological limitations should be considered. The small sample size and recruitment of adults aged 18 - 45 years from a single geographic region limit generalizability to other populations. The two-month follow-up also precludes definitive conclusions about the maintenance of treatment gains over longer periods.

5.1. Conclusions

The findings provide preliminary evidence that protocolized cognitive therapy may reduce meta-worry and experiential avoidance in individuals with panic disorder. Although the therapeutic gains remained stable over the two-month follow-up, the small sample size and short evaluation period warrant cautious interpretation. Cognitive therapy nevertheless appears promising as a nonpharmacological intervention targeting core transdiagnostic mechanisms that maintain panic symptoms. Larger longitudinal randomized controlled trials are needed to establish its long-term efficacy and broader clinical generalizability.

Footnotes

  • AI Use Disclosure:The authors declare that no generative AI tools were used in the creation of this article.

  • Authors' Contribution:Conceptualization: N. Z. A. and R. H.; methodology: N. Z. A., R. H., and F. Z. S.; formal analysis: S. K. and Z. D. B.; investigation and intervention: N. Z. A.; data curation: N. Z. A. and S. K.; writing—original draft preparation: N. Z. A. and R. H.; writing—review and editing: R. H., F. Z. S., S. K., and Z. D. B.; supervision: R. H. and F. Z. S.; project administration: R. H. All authors critically reviewed and approved the final manuscript.

  • Clinical Trial Registration Code:IRCT20260714070181N1

  • Conflict of Interests Statement:The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  • Data Availability:The dataset used in the present study will be made available by the corresponding author upon reasonable request.

  • Ethical Approval:This study was approved by the Ethics Committee of Islamic Azad University, Ahvaz Branch (Ethics Code: IR.IAU.AHVAZ.REC.1405.152).

  • Funding/Support:This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

References

  • 1.
    Hadi Ghanavat S, Mousavi SA, Keykhosrovani M. Effects of Transcranial Direct-Current Stimulation on Rumination and Self-inhibition in Patients with Panic Disorder. J Arch Mil Med. 2024;12(1). e144673. https://doi.org/10.5812/jamm-144673.
  • 2.
    Ohst B, Tuschen-Caffier B. Catastrophic misinterpretation of bodily sensations and external events in panic disorder, other anxiety disorders, and healthy subjects: A systematic review and meta-analysis. PLoS One. 2018;13(3). e0194493. [PubMed ID: 29558505]. [PubMed Central ID: PMC5860765]. https://doi.org/10.1371/journal.pone.0194493.
  • 3.
    Ohi K, Fujikane D, Takai K, Kuramitsu A, Muto Y, Sugiyama S, et al. Clinical features and genetic mechanisms of anxiety, fear, and avoidance: A comprehensive review of five anxiety disorders. Mol Psychiatry. 2025;30(10):4928-4936. [PubMed ID: 40830577]. [PubMed Central ID: PMC12436156]. https://doi.org/10.1038/s41380-025-03155-1.
  • 4.
    Lundin L. Online narratives about panic attacks: interpreted within a psychodynamic framework. Social Work in Mental Health. 2020;18(3):349-365. https://doi.org/10.1080/15332985.2020.1744500.
  • 5.
    de Jonge P, Roest AM, Lim CC, Florescu SE, Bromet EJ, Stein DJ, et al. Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depress Anxiety. 2016;33(12):1155-1177. [PubMed ID: 27775828]. [PubMed Central ID: PMC5143159]. https://doi.org/10.1002/da.22572.
  • 6.
    Capobianco L, Nordahl H. A Brief History of Metacognitive Therapy: From Cognitive Science to Clinical Practice. Cognitive and Behavioral Practice. 2023;30(1):45-54. https://doi.org/10.1016/j.cbpra.2021.11.002.
  • 7.
    Nordahl H, Vollset T, Hjemdal O. An empirical test of the metacognitive model of generalized anxiety disorder. Scand J Psychol. 2023;64(3):263-267. [PubMed ID: 36321682]. https://doi.org/10.1111/sjop.12884.
  • 8.
    Wells A. Breaking the Cybernetic Code: Understanding and Treating the Human Metacognitive Control System to Enhance Mental Health. Front Psychol. 2019;10. 2621. [PubMed ID: 31920769]. [PubMed Central ID: PMC6920120]. https://doi.org/10.3389/fpsyg.2019.02621.
  • 9.
    Antuña-Camblor C, Gómez-Salas FJ, Burgos-Julián FA, González-Vázquez A, Juarros-Basterretxea J, Rodríguez-Díaz FJ. Emotional Regulation as a Transdiagnostic Process of Emotional Disorders in Therapy: A Systematic Review and Meta-Analysis. Clin Psychol Psychother. 2024;31(3). e2997. [PubMed ID: 38747373]. https://doi.org/10.1002/cpp.2997.
  • 10.
    Wang Y, Tian J, Yang Q. Experiential Avoidance Process Model: A Review of the Mechanism for the Generation and Maintenance of Avoidance Behavior. Psychiatry Clin Psychopharmacol. 2024;34(2):179-190. [PubMed ID: 39165887]. [PubMed Central ID: PMC11332439]. https://doi.org/10.5152/pcp.2024.23777.
  • 11.
    Oussi A, Hamid K, Bouvet C. Managing emotions in panic disorder: A systematic review of studies related to emotional intelligence, alexithymia, emotion regulation, and coping. J Behav Ther Exp Psychiatry. 2023;79. 101835. [PubMed ID: 36680910]. https://doi.org/10.1016/j.jbtep.2023.101835.
  • 12.
    Navas-Casado ML, García-Sancho E, Salguero JM. Associations between maladaptive and adaptive emotion regulation strategies and aggressive behavior: A systematic review. Aggression and Violent Behavior. 2023;71. 101845. https://doi.org/10.1016/j.avb.2023.101845.
  • 13.
    Akbari M, Seydavi M, Hosseini ZS, Krafft J, Levin ME. Experiential avoidance in depression, anxiety, obsessive-compulsive related, and posttraumatic stress disorders: A comprehensive systematic review and meta-analysis. Journal of Contextual Behavioral Science. 2022;24:65-78. https://doi.org/10.1016/j.jcbs.2022.03.007.
  • 14.
    Benito K, Pittig A, Abramowitz J, Arch JJ, Chavira D, de Kleine R, et al. Mechanisms of Change in Exposure Therapy for Anxiety and Related Disorders: A Research Agenda. Clin Psychol Sci. 2025;13(4):687-719. [PubMed ID: 40855858]. [PubMed Central ID: PMC12373099]. https://doi.org/10.1177/21677026241240727.
  • 15.
    Chawla N, Anothaisintawee T, Charoenrungrueangchai K, Thaipisuttikul P, McKay GJ, Attia J, et al. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2022;376. e066084. [PubMed ID: 35045991]. [PubMed Central ID: PMC8767458]. https://doi.org/10.1136/bmj-2021-066084.
  • 16.
    Anasseri M. Effect of Cognitive-Behavioral Group Therapy on the Anxiety and Depression of War-Handicapped. J Arch Mil Med. 2021;9(1). e114085. https://doi.org/10.5812/jamm.114085.
  • 17.
    Aslam SY, Zortea T, Salkovskis P. The cognitive theory of panic disorder: A systematic narrative review. Clin Psychol Rev. 2024;113. 102483. [PubMed ID: 39180929]. https://doi.org/10.1016/j.cpr.2024.102483.
  • 18.
    Papola D, Ostuzzi G, Tedeschi F, Gastaldon C, Purgato M, Del Giovane C, et al. CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials. Psychol Med. 2023;53(3):614-624. [PubMed ID: 37132646]. [PubMed Central ID: PMC9975966]. https://doi.org/10.1017/s0033291722003683.
  • 19.
    Liu S, Xiao H, Duan Y, Shi L, Wang P, Cao L, et al. CBT treatment delivery formats for generalized anxiety disorder: a systematic review and network meta-analysis of randomized controlled trials. Transl Psychiatry. 2025;15(1). 197. [PubMed ID: 40506439]. [PubMed Central ID: PMC12162829]. https://doi.org/10.1038/s41398-025-03414-3.
  • 20.
    Pukstad E, Halvorsen J, Jensen MR, Solhaug S, Nordahl H. Do metacognitive beliefs satisfy criteria as mechanisms of change in treatment? A systematic review and evidence synthesis. Clinical Psychology Review. 2025;122. 102654. [PubMed ID: 41056592]. https://doi.org/10.1016/j.cpr.2025.102654.
  • 21.
    Wahlund T, Hesser H, Perrin S, Johansson S, Huhn V, Sörhus S, et al. Therapist-guided online metacognitive intervention for excessive worry: a randomized controlled trial with mediation analysis. Cogn Behav Ther. 2022;51(1):21-41. [PubMed ID: 34283004]. https://doi.org/10.1080/16506073.2021.1937695.
  • 22.
    Esmaeili S, Nazari G, Barati AM. The effectiveness of cognitive behavioral therapy on experiential avoidance and emotional expression of women involved in emotional divorce. Journal of Adolescent and Youth Psychological Studies (JAYPS). 2023;4(2):1-8. https://doi.org/10.61838/kman.jayps.4.2.1.
  • 23.
    Qanbari Alaee E, Saed O, Khakpoor S, Ahmadi R, Ali Mohammadi M, Yoosefi Afrashteh M, et al. The efficacy of transdiagnostic cognitive behavioural therapy on reducing negative affect, anxiety sensitivity and improving perceived control in children with emotional disorders - a randomized controlled trial. Res Psychother. 2022;25(1). [PubMed ID: 35532025]. [PubMed Central ID: PMC9153761]. https://doi.org/10.4081/ripppo.2022.588.
  • 24.
    Hüwelmeier MM, Staniczek L, Schneider S, Zhang XC, Wannemüller A, Hirschfeld G, et al. Long-term effectiveness of cognitive behavioral therapy (CBT) for children and adolescents in routine care. BMC Psychol. 2026;14(1). 663. [PubMed ID: 42092966]. [PubMed Central ID: PMC13147788]. https://doi.org/10.1186/s40359-026-04667-3.
  • 25.
    Wells A, Cartwright-Hatton S. A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav Res Ther. 2004;42(4):385-396. [PubMed ID: 14998733]. https://doi.org/10.1016/s0005-7967(03)00147-5.
  • 26.
    Zarghami M, Naderi Rajeh Y, Alipour A, Yahyavi ST, Sadeghi H. The Relationship Between Metacognition, Meta-worry, Rumination, and Cognitive-Attentional Syndrome in Iranian Combat Veterans with Post-traumatic Stress Disorder. Shiraz E-Med J. 2022;23(6). e113658. https://doi.org/10.5812/semj-113658.
  • 27.
    Hayes SC, Strosahl K, Wilson KG, Bissett RT, Pistorello J, Toarmino D, et al. Measuring Experiential Avoidance: A Preliminary Test of a Working Model. The Psychological Record. 2004;54(4):553-578. https://doi.org/10.1007/bf03395492.
  • 28.
    Imany M, Mohammadkhani S, Atashipour HS, PourHosseini P. Psychometric Validation of the Persian Version of the Experiential Avoidance Rating Scale (EARS) and Its Application in Assessing Psychological Inflexibility in Persian-Speaking Populations. BMC Psychol. 2025;13(1). 1102. [PubMed ID: 41039623]. [PubMed Central ID: PMC12492589]. https://doi.org/10.1186/s40359-025-03364-x.
  • 29.
    Stenzel KL, Keller J, Kirchner L, Rief W, Berg M. Efficacy of cognitive behavioral therapy in treating repetitive negative thinking, rumination, and worry - a transdiagnostic meta-analysis. Psychol Med. 2025;55. e31. [PubMed ID: 39916353]. [PubMed Central ID: PMC12017360]. https://doi.org/10.1017/s0033291725000017.
  • 30.
    Piro RS, Taha PH. Effectiveness of brief cognitive behavior therapy on symptoms severity in relation to social avoidance among patients with panic disorder: a randomized controlled trial. Italian Journal of Medicine. 2023;17(3):1664. https://doi.org/10.4081/itjm.2023.1664.
  • 31.
    Broman-Fulks JJ, Bergquist JJ, Hall CA, Thomas K, Kelso KC. Incremental Validity of Cognitive-Behavioral Therapy and Acceptance and Commitment Therapy Mechanisms for Anxiety and Panic Symptomology. J Cogn Psychother. 2023;37(1):43-62. [PubMed ID: 36788001]. https://doi.org/10.1891/jcpsy-d-20-00056.

Copyright

Copyright © 2026, Journal of Archives in Military Medicine. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

21
Oct
2026
The Effectiveness of Cognitive Hypnotherapy on Meta-Worry and Emotional Reactivity in Patients with Panic Disorder

The Effectiveness of Cognitive Hypnotherapy on Meta-Worry and Emotional Reactivity in Patients with Panic Disorder

Nazanin Zahra Ariamanesh,
Rezvan Homaei,
Fariba Zargar Shirazi,
Sadrollah Khosravi,
Zahra Dasht Bozorgi

Ariamanesh NZ, Homaei R, Zargar Shirazi F, Khosravi S, Dasht Bozorgi Z. The Effectiveness of Cognitive Hypnotherapy on Meta-Worry and Emotional Reactivity in Patients with Panic Disorder. J Health Rep Technol. 2026;12(4):e174679. doi: https://doi.org/10.5812/jhrt-174679

26
Aug
2024
Effects of Transcranial Direct-Current Stimulation on Rumination and Self-inhibition in Patients with Panic Disorder

Effects of Transcranial Direct-Current Stimulation on Rumination and Self-inhibition in Patients with Panic Disorder

Shokouh Hadi Ghanavat,
Seyed Asghar Mousavi,
Moloud Keykhosrovani

Hadi Ghanavat S, Mousavi SA, Keykhosrovani M. Effects of Transcranial Direct-Current Stimulation on Rumination and Self-inhibition in Patients with Panic Disorder. J Arch Mil Med. 2024;12(1):e144673. doi: https://doi.org/10.5812/jamm-144673

30
Apr
2026
Effects of Compassion-Focused Therapy on Self-criticism and Intolerance of Uncertainty in Women with Generalized Anxiety Disorder: A Randomized Controlled Trial

Effects of Compassion-Focused Therapy on Self-criticism and Intolerance of Uncertainty in Women with Generalized Anxiety Disorder: A Randomized Controlled Trial

Masoumeh Ostad,
Fariba Hafezi,
Amal Sharifi Fard,
Marzieh Talebzadeh Shoushtari

Ostad M, Hafezi F, Sharifi Fard A, Talebzadeh Shoushtari M. Effects of Compassion-Focused Therapy on Self-criticism and Intolerance of Uncertainty in Women with Generalized Anxiety Disorder: A Randomized Controlled Trial. J Health Rep Technol. 2026;12(2):e169404. doi: https://doi.org/10.5812/jhrt-169404

3
Jul
2023
Comparing the Effectiveness of Mode Deactivation Therapy and Cognitive Behavioral Therapy on Anxiety and Self-concept Clarity in Students with Generalized Anxiety Disorder

Comparing the Effectiveness of Mode Deactivation Therapy and Cognitive Behavioral Therapy on Anxiety and Self-concept Clarity in Students with Generalized Anxiety Disorder

Hajar Adelifard,
Moloud Keykhosrovani,
Seyed Asghar Mousavi

Adelifard H, Keykhosrovani M, Mousavi SA. Comparing the Effectiveness of Mode Deactivation Therapy and Cognitive Behavioral Therapy on Anxiety and Self-concept Clarity in Students with Generalized Anxiety Disorder. J Clin Res Paramed Sci. 2023;12(1):e137291. doi: https://doi.org/10.5812/jcrps-137291

8
Nov
2026
Efficacy of Existential Group Therapy and Self-Compassion Therapy in Reducing Negative Perfectionism and Self-criticism Among Individuals with Obsessive-Compulsive Personality Disorder (AI-generated illustration)

Efficacy of Existential Group Therapy and Self-Compassion Therapy in Reducing Negative Perfectionism and Self-criticism Among Individuals with Obsessive-Compulsive Personality Disorder

Saba Moeinaddini,
Hamid Mollayi Zarandi,
Alireza Manzari Tavakoli

Moeinaddini S, Mollayi Zarandi H, Manzari Tavakoli A. Efficacy of Existential Group Therapy and Self-Compassion Therapy in Reducing Negative Perfectionism and Self-criticism Among Individuals with Obsessive-Compulsive Personality Disorder. J Arch Mil Med. 2026;14(4):e174624. doi: https://doi.org/10.69107/jamm-174624

More by these authors

Nazanin Zahra AriamaneshPubMedScholar
Rezvan HomaeiPubMedScholar
Fariba Zargar ShiraziPubMedScholar
Sadrollah KhosraviPubMedScholar
Zahra Dasht BozorgiPubMedScholar
Share
Cited by
Metrics